| |
| |
|
| Insider
Information: |
Flanagan Robert J |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
13,510 |
|
|
Indirect Shares
|
805,792 |
|
|
| Direct
Value |
$767,098 |
|
|
|
Indirect Value
|
$1,015,298 |
|
|
| Total
Shares |
819,302 |
|
|
| Total
Value |
$1,782,396 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Martek Biosciences Corp |
MATK |
Director |
2011-02-25 |
0 |
2011-02-18 |
0 |
Premium* |
|
|
Castle Brands Inc |
ROX |
Director |
|
0 |
2007-05-08 |
805,792 |
Premium* |
|
|
Sagent Pharmaceuticals Inc |
SGNT |
Director |
2016-08-29 |
0 |
2016-08-29 |
0 |
Premium* |
|
|
WP Carey & Co |
WPC |
Director |
2023-07-03 |
13,510 |
2018-04-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2012-05-14 |
4 |
OE |
$4.23 |
$5,393 |
D/D |
1,275 |
3,827 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2013-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
567 |
4,394 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2013-05-13 |
4 |
OE |
$4.23 |
$5,397 |
D/D |
1,276 |
5,670 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
759 |
6,429 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
567 |
6,996 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2015-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
930 |
7,926 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2015-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
760 |
8,686 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2015-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
567 |
9,253 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
|
– • – |
2016-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
930 |
10,183 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
|
– • – |
2016-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
760 |
10,943 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
|
– • – |
2016-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
567 |
11,510 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
|
– • – |
2016-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
690 |
12,200 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2013-09-16 |
4 |
S |
$20.03 |
$10,014,100 |
I/I |
(500,000) |
609,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-05-22 |
4 |
S |
$22.02 |
$176,160 |
I/I |
(8,000) |
601,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-06-03 |
4 |
S |
$22.05 |
$176,400 |
I/I |
(8,000) |
593,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-06-04 |
4 |
S |
$22.29 |
$178,320 |
I/I |
(8,000) |
585,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-06-17 |
4 |
S |
$23.47 |
$187,760 |
I/I |
(8,000) |
577,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-06-18 |
4 |
S |
$23.26 |
$186,080 |
I/I |
(8,000) |
569,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-01 |
4 |
S |
$26.31 |
$210,480 |
I/I |
(8,000) |
561,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-02 |
4 |
S |
$26.70 |
$213,600 |
I/I |
(8,000) |
553,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-17 |
4 |
S |
$26.25 |
$210,000 |
I/I |
(8,000) |
545,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-18 |
4 |
S |
$26.11 |
$208,880 |
I/I |
(8,000) |
537,770 |
0 |
- |
|
72 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
